3DL2*090
(LN649147),
3DL2*097
(KP784303),
3DL2*091
(LN649148), 3DL2*096 (LN649157), 3DL2*092 (LN649151),
3DL2*00704 (LN606764), 3DL2*01004 (KP784304), 3DP1*01002
(KP893537), 3DP1*015 (KP893538), 3DL2*108 (LN999781),
3DL2*107
(LN999782),
3DL2*104
(LN999783),
3DL2*109
(LN999784), 3DL2*00602 (LN999785), 3DL2*106 (LN999786),
3DL2*04302
(LN999787), 3DL2*00709 (LN999788), 3DL2*
01004
(LN999790),
3DL2*103
(LN999791),
3DL2*01902
(LN999792), 3DL2*021 (LN999793), 3DL2*07902 (LN999794),
3DL2*06002 (LN999795), 3DL2*105 (LN999796), 3DL2*00109
(LN999797), 3DL2*10002 (LN999798), 2DL1*032N (KP893536),
2DL3*034 (KP784272), 2DL5A*021 (KP784273), 2DP1*00203
(KP784307), 2DP1*00204 (KP784309), 2DP1*015 (KP784306),
2DP1*016
(KP784275),
2DP1*017
(KP784308),
2DP1*018
(KP784274), 2DP1*019 (KP784310), 2DS3*008 (KP784269),
2DS5*015 (KP784270), 2DS5*016 (KP784271), HLA-C*01:02:30
(KP893072), and HLA-C*07:18 (KP893073).
Supplemental Data
Supplemental Data include four figures and four tables and can be
found with this article online at
http://dx.doi.org/10.1016/j.ajhg.
2016.06.023
.
Conflicts of Interest
S.N. and M.R. are employees of Illumina.
Acknowledgments
This study was supported by US NIH grants U01 AI090905, R01
GM109030, R01 AI17892, and U19 AI119350.
Received: January 30, 2016
Accepted: June 23, 2016
Published: August 4, 2016
Web Resources
1000 Genomes,
http://www.1000genomes.org
Coriell Biorepository,
https://catalog.coriell.org/
FASTX-Toolkit,
http://hannonlab.cshl.edu/fastx_toolkit/
GenBank,
http://www.ncbi.nlm.nih.gov/genbank/
GenDx NGSengine,
http://www.gendx.com/products/ngsengine
Haplo Stats,
http://www.mayo.edu/research/labs/statistical-genetics-
genetic-epidemiology/software
Immuno Polymorphism Database (IPD),
http://www.ebi.ac.uk/ipd/
International Histocompatibility Working Group (IHWG),
http://
www.ihwg.org/
OMIM,
http://www.omim.org/
PING executable R files,
https://github.com/wesleymarin/
PING scripts,
https://web.stanford.edu/~n0rmski/projectH/
R statistical software,
http://www.r-project.org/
UCSC Genome Browser,
http://genome.ucsc.edu
References
1.
Horton, R., Wilming, L., Rand, V., Lovering, R.C., Bruford,
E.A., Khodiyar, V.K., Lush, M.J., Povey, S., Talbot, C.C., Jr.,
Wright, M.W., et al. (2004). Gene map of the extended human
MHC. Nat. Rev. Genet. 5, 889–899
.
2.
Trowsdale, J., and Knight, J.C. (2013). Major histocompatibil-
ity complex genomics and human disease. Annu. Rev. Geno-
mics Hum. Genet. 14, 301–323
.
3.
Zinkernagel, R.M., and Doherty, P.C. (1974). Restriction of
in vitro T cell-mediated cytotoxicity in lymphocytic chorio-
meningitis within a syngeneic or semiallogeneic system. Na-
ture 248, 701–702
.
4.
Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel,
L., Lanier, L.L., Yokoyama, W.M., and Ugolini, S. (2011).
Innate or adaptive immunity? The example of natural killer
cells. Science 331, 44–49
.
5.
Campbell, K.S., and Purdy, A.K. (2011). Structure/function of
human killer cell immunoglobulin-like receptors: lessons
from polymorphisms, evolution, crystal structures and muta-
tions. Immunology 132, 315–325
.
6.
Pyo, C.W., Guethlein, L.A., Vu, Q., Wang, R., Abi-Rached, L.,
Norman, P.J., Marsh, S.G., Miller, J.S., Parham, P., and
Geraghty, D.E. (2010). Different patterns of evolution in the
centromeric and telomeric regions of group A and B haplo-
types of the human killer cell Ig-like receptor locus. PLoS
ONE 5, e15115
.
7.
McLaren, P.J., and Carrington, M. (2015). The impact of host
genetic variation on infection with HIV-1. Nat. Immunol.
16, 577–583
.
8.
Ahn, R.S., Moslehi, H., Martin, M.P., Abad-Santos, M., Bow-
cock, A.M., Carrington, M., and Liao, W. (2016). Inhibitory
KIR3DL1 alleles are associated with psoriasis. Br. J. Dermatol.
174, 449–451
.
9.
Mancusi, A., Ruggeri, L., Urbani, E., Pierini, A., Massei, M.S.,
Carotti, A., Terenzi, A., Falzetti, F., Tosti, A., Topini, F., et al.
(2015). Haploidentical hematopoietic transplantation from
KIR ligand-mismatched donors with activating KIRs reduces
nonrelapse mortality. Blood 125, 3173–3182
.
10.
Hollenbach, J.A., Pando, M.J., Caillier, S.J., Gourraud, P.A., and
Oksenberg, J.R. (2016). The killer immunoglobulin-like recep-
tor KIR3DL1 in combination with HLA-Bw4 is protective
against multiple sclerosis in African Americans. Genes Im-
mun. 17, 199–202
.
11.
Parham, P., and Moffett, A. (2013). Variable NK cell receptors
and their MHC class I ligands in immunity, reproduction
and human evolution. Nat. Rev. Immunol. 13, 133–144
.
12.
Jiang, W., Johnson, C., Jayaraman, J., Simecek, N., Noble, J.,
Moffatt, M.F., Cookson, W.O., Trowsdale, J., and Traherne,
J.A. (2012). Copy number variation leads to considerable
diversity for B but not A haplotypes of the human KIR
genes encoding NK cell receptors. Genome Res. 22, 1845–
1854
.
13.
Norman, P.J., Abi-Rached, L., Gendzekhadze, K., Hammond,
J.A., Moesta, A.K., Sharma, D., Graef, T., McQueen, K.L.,
Guethlein, L.A., Carrington, C.V., et al. (2009). Meiotic recom-
bination generates rich diversity in NK cell receptor genes,
alleles, and haplotypes. Genome Res. 19, 757–769
.
14.
Wilson, M.J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer,
D., Beck, S., and Trowsdale, J. (2000). Plasticity in the organi-
zation and sequences of human KIR/ILT gene families. Proc.
Natl. Acad. Sci. USA 97, 4778–4783
.
15.
Robinson, J., Halliwell, J.A., Hayhurst, J.D., Flicek, P., Parham,
P., and Marsh, S.G. (2015). The IPD and IMGT/HLA database:
allele variant databases. Nucleic Acids Res. 43, D423–D431
.
16.
Norman, P.J., Hollenbach, J.A., Nemat-Gorgani, N., Gueth-
lein, L.A., Hilton, H.G., Pando, M.J., Koram, K.A., Riley,
E.M., Abi-Rached, L., and Parham, P. (2013). Co-evolution of
388
The American Journal of Human Genetics 99, 375–391, August 4, 2016